Integrating pharmacies into public health program planning for pandemic influenza vaccine response.
Identifieur interne : 000491 ( PubMed/Checkpoint ); précédent : 000490; suivant : 000492Integrating pharmacies into public health program planning for pandemic influenza vaccine response.
Auteurs : Thomas J. Fitzgerald [États-Unis] ; Yoonjae Kang [États-Unis] ; Carolyn B. Bridges [États-Unis] ; Todd Talbert [États-Unis] ; Sara J. Vagi [États-Unis] ; Brock Lamont [États-Unis] ; Samuel B. Graitcer [États-Unis]Source :
- Vaccine [ 1873-2518 ] ; 2016.
Descripteurs français
- KwdFr :
- Grippe humaine (), Humains, Immunisation, Pandémies (), Pharmaciens, Pharmacies, Planification des mesures d'urgence en cas de catastrophe (), Prestation intégrée de soins de santé, Protection civile (), Protection civile (économie), Santé publique, Sous-type H1N1 du virus de la grippe A (immunologie), Vaccins antigrippaux (administration et posologie), États-Unis d'Amérique.
- MESH :
- administration et posologie : Vaccins antigrippaux.
- immunologie : Sous-type H1N1 du virus de la grippe A.
- économie : Protection civile.
- Grippe humaine, Humains, Immunisation, Pandémies, Pharmaciens, Pharmacies, Planification des mesures d'urgence en cas de catastrophe, Prestation intégrée de soins de santé, Protection civile, Santé publique, États-Unis d'Amérique.
- Wicri :
- geographic : États-Unis.
English descriptors
- KwdEn :
- Centers for Disease Control and Prevention, U.S., Civil Defense (economics), Civil Defense (statistics & numerical data), Delivery of Health Care, Integrated, Disaster Planning (statistics & numerical data), Humans, Immunization, Influenza A Virus, H1N1 Subtype (immunology), Influenza Vaccines (administration & dosage), Influenza, Human (prevention & control), Pandemics (prevention & control), Pharmacies, Pharmacists, Public Health, United States, Vaccination Coverage.
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- geographic : United States.
- economics : Civil Defense.
- immunology : Influenza A Virus, H1N1 Subtype.
- prevention & control : Influenza, Human, Pandemics.
- statistics & numerical data : Civil Defense, Disaster Planning.
- Centers for Disease Control and Prevention, U.S., Delivery of Health Care, Integrated, Humans, Immunization, Pharmacies, Pharmacists, Public Health, Vaccination Coverage.
Abstract
During an influenza pandemic, to achieve early and rapid vaccination coverage and maximize the benefit of an immunization campaign, partnerships between public health agencies and vaccine providers are essential. Immunizing pharmacists represent an important group for expanding access to pandemic vaccination. However, little is known about nationwide coordination between public health programs and pharmacies for pandemic vaccine response planning.
DOI: 10.1016/j.vaccine.2016.09.020
PubMed: 27686834
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:27686834Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Integrating pharmacies into public health program planning for pandemic influenza vaccine response.</title><author><name sortKey="Fitzgerald, Thomas J" sort="Fitzgerald, Thomas J" uniqKey="Fitzgerald T" first="Thomas J" last="Fitzgerald">Thomas J. Fitzgerald</name><affiliation wicri:level="2"><nlm:affiliation>IHRC, Inc, Atlanta, GA, United States; Oak Ridge Institute for Science and Education, Oak Ridge, TN, United States; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: ymi8@cdc.gov.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>IHRC, Inc, Atlanta, GA, United States; Oak Ridge Institute for Science and Education, Oak Ridge, TN, United States; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Kang, Yoonjae" sort="Kang, Yoonjae" uniqKey="Kang Y" first="Yoonjae" last="Kang">Yoonjae Kang</name><affiliation wicri:level="2"><nlm:affiliation>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Bridges, Carolyn B" sort="Bridges, Carolyn B" uniqKey="Bridges C" first="Carolyn B" last="Bridges">Carolyn B. Bridges</name><affiliation wicri:level="2"><nlm:affiliation>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Talbert, Todd" sort="Talbert, Todd" uniqKey="Talbert T" first="Todd" last="Talbert">Todd Talbert</name><affiliation wicri:level="2"><nlm:affiliation>Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Vagi, Sara J" sort="Vagi, Sara J" uniqKey="Vagi S" first="Sara J" last="Vagi">Sara J. Vagi</name><affiliation wicri:level="2"><nlm:affiliation>Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Lamont, Brock" sort="Lamont, Brock" uniqKey="Lamont B" first="Brock" last="Lamont">Brock Lamont</name><affiliation wicri:level="2"><nlm:affiliation>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Graitcer, Samuel B" sort="Graitcer, Samuel B" uniqKey="Graitcer S" first="Samuel B" last="Graitcer">Samuel B. Graitcer</name><affiliation wicri:level="2"><nlm:affiliation>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27686834</idno><idno type="pmid">27686834</idno><idno type="doi">10.1016/j.vaccine.2016.09.020</idno><idno type="wicri:Area/PubMed/Corpus">000486</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000486</idno><idno type="wicri:Area/PubMed/Curation">000486</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000486</idno><idno type="wicri:Area/PubMed/Checkpoint">000491</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000491</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Integrating pharmacies into public health program planning for pandemic influenza vaccine response.</title><author><name sortKey="Fitzgerald, Thomas J" sort="Fitzgerald, Thomas J" uniqKey="Fitzgerald T" first="Thomas J" last="Fitzgerald">Thomas J. Fitzgerald</name><affiliation wicri:level="2"><nlm:affiliation>IHRC, Inc, Atlanta, GA, United States; Oak Ridge Institute for Science and Education, Oak Ridge, TN, United States; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: ymi8@cdc.gov.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>IHRC, Inc, Atlanta, GA, United States; Oak Ridge Institute for Science and Education, Oak Ridge, TN, United States; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Kang, Yoonjae" sort="Kang, Yoonjae" uniqKey="Kang Y" first="Yoonjae" last="Kang">Yoonjae Kang</name><affiliation wicri:level="2"><nlm:affiliation>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Bridges, Carolyn B" sort="Bridges, Carolyn B" uniqKey="Bridges C" first="Carolyn B" last="Bridges">Carolyn B. Bridges</name><affiliation wicri:level="2"><nlm:affiliation>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Talbert, Todd" sort="Talbert, Todd" uniqKey="Talbert T" first="Todd" last="Talbert">Todd Talbert</name><affiliation wicri:level="2"><nlm:affiliation>Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Vagi, Sara J" sort="Vagi, Sara J" uniqKey="Vagi S" first="Sara J" last="Vagi">Sara J. Vagi</name><affiliation wicri:level="2"><nlm:affiliation>Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Lamont, Brock" sort="Lamont, Brock" uniqKey="Lamont B" first="Brock" last="Lamont">Brock Lamont</name><affiliation wicri:level="2"><nlm:affiliation>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Graitcer, Samuel B" sort="Graitcer, Samuel B" uniqKey="Graitcer S" first="Samuel B" last="Graitcer">Samuel B. Graitcer</name><affiliation wicri:level="2"><nlm:affiliation>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author></analytic><series><title level="j">Vaccine</title><idno type="eISSN">1873-2518</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Centers for Disease Control and Prevention, U.S.</term><term>Civil Defense (economics)</term><term>Civil Defense (statistics & numerical data)</term><term>Delivery of Health Care, Integrated</term><term>Disaster Planning (statistics & numerical data)</term><term>Humans</term><term>Immunization</term><term>Influenza A Virus, H1N1 Subtype (immunology)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (prevention & control)</term><term>Pandemics (prevention & control)</term><term>Pharmacies</term><term>Pharmacists</term><term>Public Health</term><term>United States</term><term>Vaccination Coverage</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Grippe humaine ()</term><term>Humains</term><term>Immunisation</term><term>Pandémies ()</term><term>Pharmaciens</term><term>Pharmacies</term><term>Planification des mesures d'urgence en cas de catastrophe ()</term><term>Prestation intégrée de soins de santé</term><term>Protection civile ()</term><term>Protection civile (économie)</term><term>Santé publique</term><term>Sous-type H1N1 du virus de la grippe A (immunologie)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>United States</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Civil Defense</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term><term>Pandemics</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Civil Defense</term><term>Disaster Planning</term></keywords><keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Protection civile</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Centers for Disease Control and Prevention, U.S.</term><term>Delivery of Health Care, Integrated</term><term>Humans</term><term>Immunization</term><term>Pharmacies</term><term>Pharmacists</term><term>Public Health</term><term>Vaccination Coverage</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Grippe humaine</term><term>Humains</term><term>Immunisation</term><term>Pandémies</term><term>Pharmaciens</term><term>Pharmacies</term><term>Planification des mesures d'urgence en cas de catastrophe</term><term>Prestation intégrée de soins de santé</term><term>Protection civile</term><term>Santé publique</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>États-Unis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">During an influenza pandemic, to achieve early and rapid vaccination coverage and maximize the benefit of an immunization campaign, partnerships between public health agencies and vaccine providers are essential. Immunizing pharmacists represent an important group for expanding access to pandemic vaccination. However, little is known about nationwide coordination between public health programs and pharmacies for pandemic vaccine response planning.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27686834</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>46</Issue><PubDate><Year>2016</Year><Month>11</Month><Day>04</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Integrating pharmacies into public health program planning for pandemic influenza vaccine response.</ArticleTitle><Pagination><MedlinePgn>5643-5648</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(16)30833-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2016.09.020</ELocationID><Abstract><AbstractText Label="BACKGROUND">During an influenza pandemic, to achieve early and rapid vaccination coverage and maximize the benefit of an immunization campaign, partnerships between public health agencies and vaccine providers are essential. Immunizing pharmacists represent an important group for expanding access to pandemic vaccination. However, little is known about nationwide coordination between public health programs and pharmacies for pandemic vaccine response planning.</AbstractText><AbstractText Label="METHODS">To assess relationships and planning activities between public health programs and pharmacies, we analyzed data from Centers for Disease Control and Prevention assessments of jurisdictions that received immunization and emergency preparedness funding from 2012 to 2015.</AbstractText><AbstractText Label="RESULTS">Forty-seven (88.7%) of 53 jurisdictions reported including pharmacies in pandemic vaccine distribution plans, 24 (45.3%) had processes to recruit pharmacists to vaccinate, and 16 (30.8%) of 52 established formal relationships with pharmacies. Most jurisdictions plan to allocate less than 10% of pandemic vaccine supply to pharmacies.</AbstractText><AbstractText Label="DISCUSSION">While most jurisdictions plan to include pharmacies as pandemic vaccine providers, work is needed to establish formalized agreements between public health departments and pharmacies to improve pandemic preparedness coordination and ensure that vaccinating pharmacists are fully utilized during a pandemic.</AbstractText><CopyrightInformation>Copyright © 2016 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fitzgerald</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>IHRC, Inc, Atlanta, GA, United States; Oak Ridge Institute for Science and Education, Oak Ridge, TN, United States; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: ymi8@cdc.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Yoonjae</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bridges</LastName><ForeName>Carolyn B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talbert</LastName><ForeName>Todd</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vagi</LastName><ForeName>Sara J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamont</LastName><ForeName>Brock</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graitcer</LastName><ForeName>Samuel B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CC999999</GrantID><Agency>Intramural CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002487" MajorTopicYN="N">Centers for Disease Control and Prevention, U.S.</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002959" MajorTopicYN="N">Civil Defense</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019033" MajorTopicYN="Y">Delivery of Health Care, Integrated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004189" MajorTopicYN="N">Disaster Planning</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010594" MajorTopicYN="Y">Pharmacies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010595" MajorTopicYN="N">Pharmacists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="Y">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>06</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>09</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>09</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27686834</ArticleId><ArticleId IdType="pii">S0264-410X(16)30833-7</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2016.09.020</ArticleId><ArticleId IdType="pmc">PMC5206751</ArticleId><ArticleId IdType="mid">NIHMS824406</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Disaster Med Public Health Prep. 2011 Dec;5(4):253-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22146661</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2012 Dec 17;31(1):196-201</Citation><ArticleIdList><ArticleId IdType="pubmed">23123022</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Recomm Rep. 2014 Sep 26;63(RR-06):1-18</Citation><ArticleIdList><ArticleId IdType="pubmed">25254666</ArticleId></ArticleIdList></Reference><Reference><Citation>Disaster Med Public Health Prep. 2012 Mar;6(1):44-52</Citation><ArticleIdList><ArticleId IdType="pubmed">22490936</ArticleId></ArticleIdList></Reference><Reference><Citation>Disaster Med Public Health Prep. 2011 Dec;5(4):300-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22146669</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2015 May 1;60 Suppl 1:S20-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25878298</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Pharm Assoc (2003). 2003 Nov-Dec;43(6):694-701</Citation><ArticleIdList><ArticleId IdType="pubmed">14717266</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Géorgie (États-Unis)</li></region></list><tree><country name="États-Unis"><region name="Géorgie (États-Unis)"><name sortKey="Fitzgerald, Thomas J" sort="Fitzgerald, Thomas J" uniqKey="Fitzgerald T" first="Thomas J" last="Fitzgerald">Thomas J. Fitzgerald</name></region><name sortKey="Bridges, Carolyn B" sort="Bridges, Carolyn B" uniqKey="Bridges C" first="Carolyn B" last="Bridges">Carolyn B. Bridges</name><name sortKey="Graitcer, Samuel B" sort="Graitcer, Samuel B" uniqKey="Graitcer S" first="Samuel B" last="Graitcer">Samuel B. Graitcer</name><name sortKey="Kang, Yoonjae" sort="Kang, Yoonjae" uniqKey="Kang Y" first="Yoonjae" last="Kang">Yoonjae Kang</name><name sortKey="Lamont, Brock" sort="Lamont, Brock" uniqKey="Lamont B" first="Brock" last="Lamont">Brock Lamont</name><name sortKey="Talbert, Todd" sort="Talbert, Todd" uniqKey="Talbert T" first="Todd" last="Talbert">Todd Talbert</name><name sortKey="Vagi, Sara J" sort="Vagi, Sara J" uniqKey="Vagi S" first="Sara J" last="Vagi">Sara J. Vagi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000491 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000491 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:27686834
|texte= Integrating pharmacies into public health program planning for pandemic influenza vaccine response.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:27686834" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |